Here is an example of how the Global Fund makes a significant difference to those living with Tuberculosis……
Source: Health E News
20th May, 2019
A major shot in the arm is set to boost South Africa’s fight against tuberculosis. A grant from the Global Fund is expected to boost the implementation of tuberculosis drug 3HP, a short course TB preventative therapy regimen that combines TB drugs, isoniazid and rifapentine. South African National Aids Council CEO, Sandile Buthelezi is excited that the grant will assist with the rolling out of 3HP, which is recommended for people living with HIV. Click here for the full article.